Back to MF Merit Financial Group, LLC

IBRXIBRX
14 quarters

Position history for MFMerit Financial Group, LLC's holdings in IMMUNITYBIO INC

Merit Financial Group, LLC holds 47,916 shares of IBRX (IMMUNITYBIO INC), worth $419,505 as of 2026-Q2. The position was increased (+7.5% shares). IBRX represents 0.0% of Merit Financial Group, LLC's portfolio.

Current Value

$419,505

Current Shares

47,916

Total Value Change

+$376,189

Total Shares Change

+24,116

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
47,916
+7.5%
$419,5050.0%$8.76
26
2026-Q1
Increased
44,565
+0.6%
$341,8140.0%$10.00
24
2025-Q4
Decreased
44,308
-1.6%
$87,7300.0%$1.98
0
2025-Q3
Decreased
45,018
-8.4%
$110,7440.0%$2.57
0
2025-Q2
Increased
49,175
+11.2%
$129,8220.0%$2.70
25
2025-Q1
Increased
44,244
+1.0%
$133,1740.0%$3.14
22
2024-Q4
Increased
43,809
+0.0%
$112,1510.0%$2.68
22
2024-Q3
Decreased
43,800
-0.0%
$162,9360.0%$3.93
0
2024-Q2
Increased
43,819
+0.0%
$276,9360.0%$6.32
23
2024-Q1
Increased
43,812
+0.0%
$400,8800.0%$5.37
24
2023-Q4
Unchanged
43,800
0.0%
$219,8760.0%$5.02
0
2023-Q3
Increased
43,800
+84.0%
$74,0220.0%$1.69
33
2023-Q2
Unchanged
23,800
0.0%
$66,1640.0%$2.72
0
2023-Q1
New
23,800
-
$43,3160.0%$1.76
28

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used